https://virtechbio.com/ 2024-05-23 https://virtechbio.com/news/ 2026-10-26 https://virtechbio.com/patents/ 2026-09-01 https://virtechbio.com/partners/ 2026-08-17 https://virtechbio.com/virtechbio-development-lab/ 2023-10-09 https://virtechbio.com/2026/07/new-mtec-contract-funds-oxybridge-manufacturing-scale-up/ 2026-07-01 https://virtechbio.com/2026/06/gbi-biomanufacturing-selected-to-take-oxybridge-to-clinical-scale/ 2026-06-01 https://virtechbio.com/2026/05/virtech-bio-adds-us-and-european-patents-for-oxybridge-in-2026/ 2026-05-29 https://virtechbio.com/2025/08/virtech-bio-presents-oxybridge-preclinical-safety-results-at-mhsrs-2025/ 2025-08-07 https://virtechbio.com/2024/03/fda-and-virtech-bio-reach-agreement-on-phase-i-trial-design-for-oxybridge/ 2024-03-01 https://virtechbio.com/2023/10/virtech-bio-expands-scientific-advisory-board-with-medical-and-industry-leaders/ 2023-10-18 https://virtechbio.com/2023/01/a-successful-2022-for-our-team-and-the-advancement-of-oxybridge/ 2023-01-04 https://virtechbio.com/2022/11/virtech-bio-presenting-at-the-florida-venture-summit-dec-6-2022/ 2022-11-29 https://virtechbio.com/2022/09/startup-creates-artificial-blood-and-receives-funding-from-the-pentagon/ 2022-09-01 https://virtechbio.com/2022/09/startup-cria-sangue-artificial-e-recebe-aporte-do-pentagono/ 2022-09-01 https://virtechbio.com/2022/03/dr-dallas-hack-appointed-as-ceo-of-virtech-bio-2/ 2022-03-17